Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 4Completed 2Withdrawn 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Thrombocytopenia 2

Interventions

eltrombopag 8romiplostim 5Cytarabine 4Filgrastim 3Etoposide 3Daunorubicin 3Carboplatin 3oprelvekin 2fludarabine phosphate 2avatrombopag 2Thrombopoietin 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Lenalidomide 2Interleukin-11 2Ifosfamide 2Doxorubicin 2Cyclosporine 2Busulfan 2sargramostim 1ofatumumab 1lusutrombopag 1leridistim 1bryostatin 1 1angiotensin I (1-7) 1alvocidib 1Vitamin E 1Vitamin B 12 1Vincristine 1Tranexamic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Thrombocytopenia × avatrombopag × Clear all
NCT03471078 2023-09-28

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Sobi, Inc.

Phase 3 Completed
122 enrolled 19 charts
Classical hematology

Thrombocytopenia

NCT04609891 2022-04-29

Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors

Anhui Provincial Cancer Hospital

Phase NA Completed
74 enrolled
Classical hematology

Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡